Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 1830

1.

Cerebrospinal fluid progranulin is associated with increased cortical thickness in early stages of Alzheimer's disease.

Batzu L, Westman E, Pereira JB; Alzheimer's Disease Neuroimaging Initiative.

Neurobiol Aging. 2019 Dec 20. pii: S0197-4580(19)30440-3. doi: 10.1016/j.neurobiolaging.2019.12.012. [Epub ahead of print]

PMID:
31980280
2.

Cognitive reserve predicts future executive function decline in older adults with Alzheimer's disease pathology but not age-associated pathology.

McKenzie C, Bucks RS, Weinborn M, Bourgeat P, Salvado O, Gavett BE; Alzheimer's Disease Neuroimaging Initiative.

Neurobiol Aging. 2020 Jan 3. pii: S0197-4580(19)30451-8. doi: 10.1016/j.neurobiolaging.2019.12.022. [Epub ahead of print]

PMID:
31980279
3.

Morbigenous brain region and gene detection with a genetically evolved random neural network cluster approach in late mild cognitive impairment.

Bi XA, Liu Y, Xie Y, Hu X, Jiang Q; Alzheimer’s Disease Neuroimaging Initiative.

Bioinformatics. 2020 Jan 23. pii: btz967. doi: 10.1093/bioinformatics/btz967. [Epub ahead of print]

PMID:
31971559
4.

Soluble TREM2 and Inflammatory Proteins in Alzheimer's Disease Cerebrospinal Fluid.

Rauchmann BS, Sadlon A, Perneczky R; Alzheimer’s Disease Neuroimaging Initiative.

J Alzheimers Dis. 2020 Jan 13. doi: 10.3233/JAD-191120. [Epub ahead of print]

PMID:
31958095
5.

Functional brain architecture is associated with the rate of tau accumulation in Alzheimer's disease.

Franzmeier N, Neitzel J, Rubinski A, Smith R, Strandberg O, Ossenkoppele R, Hansson O, Ewers M; Alzheimer’s Disease Neuroimaging Initiative (ADNI).

Nat Commun. 2020 Jan 17;11(1):347. doi: 10.1038/s41467-019-14159-1.

6.

Longitudinal trajectory of Amyloid-related hippocampal subfield atrophy in nondemented elderly.

Zhang L, Mak E, Reilhac A, Shim HY, Ng KK, Ong MQW, Ji F, Chong EJY, Xu X, Wong ZX, Stephenson MC, Venketasubramanian N, Tan BY, O'Brien JT, Zhou JH, Chen CLH; Alzheimer's Disease Neuroimaging Initiative.

Hum Brain Mapp. 2020 Jan 14. doi: 10.1002/hbm.24928. [Epub ahead of print]

PMID:
31944479
7.

Erratum to 'Altered Temporal Organization of Brief Spontaneous Brain Activities in Patients with Alzheimer's Disease' [Neuroscience 425C (2020) 1-11].

Ma X, Zhuo Z, Wei L, Ma Z, Li Z, Li H; Alzheimer's Disease Neuroimaging Initiative.

Neuroscience. 2020 Jan 11;428:111. doi: 10.1016/j.neuroscience.2020.01.001. [Epub ahead of print] No abstract available.

PMID:
31935367
8.

MRI and cognitive scores complement each other to accurately predict Alzheimer's dementia 2 to 7 years before clinical onset.

Zandifar A, Fonov VS, Ducharme S, Belleville S, Collins DL; Alzheimer’s Disease Neuroimaging Initiative.

Neuroimage Clin. 2019 Dec 16;25:102121. doi: 10.1016/j.nicl.2019.102121. [Epub ahead of print]

9.

Genome-wide association study of cerebrospinal fluid neurofilament light levels in non-demented elders.

Niu LD, Xu W, Li JQ, Tan CC, Cao XP, Yu J, Tan L; Alzheimer’s Disease Neuroimaging Initiative.

Ann Transl Med. 2019 Nov;7(22):657. doi: 10.21037/atm.2019.10.66.

10.

Body mass index is associated with smaller medial temporal lobe volume in those at risk for Alzheimer's disease.

Hayes JP, Moody JN, Roca JG, Hayes SM; Alzheimer's Disease Neuroimaging Initiative.

Neuroimage Clin. 2019 Dec 27;25:102156. doi: 10.1016/j.nicl.2019.102156. [Epub ahead of print]

11.

Hypergraph based multi-task feature selection for multimodal classification of Alzheimer's disease.

Shao W, Peng Y, Zu C, Wang M, Zhang D; Alzheimer's Disease Neuroimaging Initiative.

Comput Med Imaging Graph. 2019 Dec 19;80:101663. doi: 10.1016/j.compmedimag.2019.101663. [Epub ahead of print]

PMID:
31923610
12.

Longitudinal basal forebrain degeneration interacts with TREM2/C3 biomarkers of inflammation in pre-symptomatic Alzheimer's disease.

Schmitz TW, Soreq H, Poirier J, Spreng RN; Alzheimer's Disease Neuroimaging Initiative.

J Neurosci. 2020 Jan 8. pii: 1184-19. doi: 10.1523/JNEUROSCI.1184-19.2019. [Epub ahead of print]

PMID:
31915256
13.

Two-stage Bayesian GWAS of 9576 individuals identifies SNP regions that are targeted by miRNAs inversely expressed in Alzheimer's and cancer.

Pathak GA, Zhou Z, Silzer TK, Barber RC, Phillips NR; Alzheimer's Disease Neuroimaging Initiative, Breast and Prostate Cancer Cohort Consortium, and Alzheimer's Disease Genetics Consortium.

Alzheimers Dement. 2020 Jan;16(1):162-177. doi: 10.1002/alz.12003.

PMID:
31914222
14.

Blood-based protein predictors of dementia severity as measured by δ: Replication across biofluids and cohorts.

Royall DR, Bishnoi RJ, Palmer RF; Alzheimer's Disease Neuroimaging Initiative.

Alzheimers Dement (Amst). 2019 Nov 6;11:763-774. doi: 10.1016/j.dadm.2019.09.002. eCollection 2019 Dec.

15.

Brain Volume Predicts Behavioral and Psychological Symptoms in Alzheimer's Disease.

Boublay N, Bouet R, Dorey JM, Padovan C, Makaroff Z, Fédérico D, Gallice I, Barrellon MO, Robert P, Moreaud O, Rouch I, Krolak-Salmon P; Alzheimer’s Disease Neuroimaging Initiative.

J Alzheimers Dis. 2020 Jan 2. doi: 10.3233/JAD-190612. [Epub ahead of print]

PMID:
31903989
16.

Neurodegenerative Patterns of Cognitive Clusters of Early-Onset Alzheimer's Disease Subjects: Evidence for Disease Heterogeneity.

Phillips ML, Stage EC Jr, Lane KA, Gao S, Risacher SL, Goukasian N, Saykin AJ, Carrillo MC, Dickerson BC, Rabinovici GD, Apostolova LG; Alzheimer’s Disease Neuroimaging Initiative.

Dement Geriatr Cogn Disord. 2020 Jan 3:1-12. doi: 10.1159/000504341. [Epub ahead of print]

PMID:
31901905
17.

Dysregulated Fc gamma receptor-mediated phagocytosis pathway in Alzheimer's disease: network-based gene expression analysis.

Park YH, Hodges A, Risacher SL, Lin K, Jang JW, Ahn S, Kim S, Lovestone S, Simmons A, Weiner MW, Saykin AJ, Nho K; AddNeuroMed consortium and the Alzheimer's Disease Neuroimaging Initiative.

Neurobiol Aging. 2019 Dec 10. pii: S0197-4580(19)30428-2. doi: 10.1016/j.neurobiolaging.2019.12.001. [Epub ahead of print]

PMID:
31901293
18.

Cerebellar Volume Is Associated with Cognitive Decline in Mild Cognitive Impairment: Results from ADNI.

Lin CY, Chen CH, Tom SE, Kuo SH; Alzheimer’s Disease Neuroimaging Initiative.

Cerebellum. 2020 Jan 4. doi: 10.1007/s12311-019-01099-1. [Epub ahead of print]

PMID:
31900856
19.

Hippocampal neuroimaging-informed clinical trial enrichment tool for amnestic mild cognitive impairment using open data.

Conrado DJ, Burton J, Hill D, Willis B, Sinha V, Stone J, Coello N, Wang W, Chen D, Nicholas T, Gold M, Hartley E, Kern VD, Romero K; Alzheimer's Disease Neuroimaging Initiative; Critical Path for Alzheimer's Disease (CPAD).

Clin Pharmacol Ther. 2020 Jan 3. doi: 10.1002/cpt.1766. [Epub ahead of print]

PMID:
31899810
20.

FCN Based Label Correction for Multi-Atlas Guided Organ Segmentation.

Zhu H, Adeli E, Shi F, Shen D; Alzheimer’s Disease Neuroimaging Initiative.

Neuroinformatics. 2020 Jan 2. doi: 10.1007/s12021-019-09448-5. [Epub ahead of print]

PMID:
31898145

Supplemental Content

Loading ...
Support Center